Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Equity Income (2024 - 2025)

PAVmed has reported Equity Income over the past 2 years, most recently at $2.5 million for Q4 2025.

  • Quarterly results put Equity Income at $2.5 million for Q4 2025, up 1903.2% from a year ago — trailing twelve months through Dec 2025 was $8.5 million (changed N/A YoY), and the annual figure for FY2025 was $8.5 million, up 1494.55%.
  • Equity Income for Q4 2025 was $2.5 million at PAVmed, up from -$4.4 million in the prior quarter.
  • Over the last five years, Equity Income for PAVM hit a ceiling of $21.0 million in Q1 2025 and a floor of -$10.6 million in Q2 2025.